Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    Pharma needs to evolve from customer-centricity to stakeholder-centricity

    White Papers and Resources | June 23, 2017 | An agency called Owen

    Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders.

    How to plan, execute and refine an excellent congress experience

    White Papers and Resources | June 22, 2017 | Blue Latitude Health

    Medical congresses are one of the most important and intensive marketing activities a company can undertake. Here, Account Director Dolan Desai and Senior Creative Copywriter Dale Choate give you the...

    How can pharma help the NHS capitalise on its data?

    White Papers and Resources | June 21, 2017 | Wilmington Healthcare

    Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services

    21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare

    White Papers and Resources | June 20, 2017 | Blue Latitude Health

    The 21st Century Cures Act has transformed the US drug development landscape. David Cooney explores the implications of the Act for pharmaceutical companies and reveals how it can be leveraged.

    Using insights to effect behaviour change

    Press Releases | June 20, 2017 | Lucid Group Communications Limited

    The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

    Spotlight on Events

    Press Releases | June 12, 2017 | Porterhouse Medical Group

    Porterhouse has delivered many successful global programmes in 2017 so far. Read about our dedicated events team ...

    17 In Search of the Invisible Army

    White Papers and Resources | June 8, 2017 | Havas Lynx

    The caregivers' story

    All five of Lucid’s entries reach the shortlist for Communiqué 2017

    Press Releases | June 8, 2017 | Lucid Group Communications Limited

    Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...

    Research Partnership announces several new appointments

    Press Releases | June 7, 2017 | Inizio

    Research Partnership is delighted to welcome Anne Cunningham and Morten Andersen and announce that Sue Rees has joined our specialist Emerging Markets team.

    PMRC San Francisco 2017

    White Papers and Resources | June 7, 2017 | Inizio

    We are delighted to be presenting a paper and exhibiting at the Pharmaceutical Market Research Conference 13-14 June in Bay Area close to our new office in San Francisco.Representing Research...